← Back to Browse
EFTA01268400.pdf
AI Summary
An email exchange regarding cost basis information for securities transfers, including specific stock holdings in companies like Foundation Medicine Inc and Sangamo Therapeutics Inc. The document appears to be related to financial asset transfers involving Richard Kahn. [Rating: 6/10 - Document shows substantial financial transactions with specific dollar amounts and named individuals, indicating potential asset transfers of significant value]
Flags
financial_transactions
Extracted Entities
| Name | Type | Context |
|---|---|---|
| New York NY | location | Location associated with Richard Kahn |
| Foundation Medicine Inc | organization | Stock holding with cost basis of $1,265,037 |
| Sangamo Therapeutics Inc | organization | Stock holding with cost basis of $422,214 |
| Paul Barrett | person | CC'd on email about cost basis of securities |
| Richard Kahn | person | Individual associated with securities transfers, located in New York NY |
Full Text
From: BiaaarsUialui To: Cc: Paul Barrett Subject: Re: Cost Basis Date: Tuesday. October 10. 2017 2:17:07 PM Cost basis of securities transferred in are as follows: Thank you Purchase Quantity A§FehPRVIEIP@R&ip Inc. (Formerly Date Cost 1/16/01 70,500 1,500,000 Dress Barn 1.3.11) Foundation Medicine Inc 1/16/14 49.830 1,265,037 Sangamo Therapeutics Inc 5/28/13 50,000 422,214 Richard Kahn New York NY 10022 Phon Cel On Oct 10 2017 at 2:09 PM. < wrote: Hello, Richard. I wanted to follow up with you. My understanding is that there may be some questions around cost basis for the assets that you transferred over. How may I support you? <image003.jpg> CONFIDENTIAL SDNY_GM_0001 2327 EFTA_00122976 EFTA01268400